US Stock MarketDetailed Quotes

TRML Tourmaline Bio

Watchlist
  • 16.850
  • -0.390-2.26%
Close Aug 30 16:00 ET
  • 16.850
  • 0.0000.00%
Post 20:01 ET
432.06MMarket Cap-8136P/E (TTM)

Tourmaline Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
34.18%21.97M
133.50%17.52M
130.49%45.41M
117.10%6.32M
-52.68%9.38M
16.37M
7.5M
19.7M
-16,450.00%-36.95M
19.82M
Selling and administrative expenses
224.84%6.24M
349.89%6.14M
499.59%13.04M
31.64%-8.28M
88.23%9.11M
--1.92M
--1.37M
--2.18M
-7,101.73%-12.11M
--4.84M
-General and administrative expense
224.84%6.24M
349.89%6.14M
499.59%13.04M
31.64%-8.28M
88.23%9.11M
--1.92M
--1.37M
--2.18M
-7,101.73%-12.11M
--4.84M
Research and development costs
8.86%15.73M
85.37%11.38M
84.69%32.37M
158.77%14.6M
-98.22%267K
--14.45M
--6.14M
--17.53M
-46,964.15%-24.84M
--14.98M
Operating profit
-34.18%-21.97M
-133.50%-17.52M
-130.49%-45.41M
-117.10%-6.32M
52.68%-9.38M
-16.37M
-7.5M
-19.7M
16,450.00%36.95M
-19.82M
Net non-operating interest income expense
136.08%1.92M
812K
Total other finance cost
----
----
----
----
-136.08%-1.92M
----
----
----
----
---812K
Other net income (expense)
1,730.20%4.48M
4.21M
3.29M
13.71M
449K
245K
Special income (charges)
----
----
----
----
--449K
----
----
----
----
--0
-Less:Restructuring and merger&acquisition
----
----
----
----
--89K
----
----
----
----
--0
-Gain on sale of property,plant,equipment
----
----
----
----
--538K
----
----
----
----
--0
Other non- operating income (expenses)
1,730.20%4.48M
--4.21M
--3.29M
----
----
--245K
----
----
----
----
Income before tax
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-94.04%2.13M
63.10%-7.02M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
-19.01M
Income tax
Net income
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-94.04%2.13M
63.10%-7.02M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
-19.01M
Net income continuous Operations
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-94.04%2.13M
63.10%-7.02M
---16.13M
---7.5M
---19.7M
15,880.97%35.67M
---19.01M
Minority interest income
Net income attributable to the parent company
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-94.04%2.13M
63.10%-7.02M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
-19.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-94.04%2.13M
63.10%-7.02M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
-19.01M
Basic earnings per share
14.26%-0.68
-49.10%-0.55
-815.62%-8.87
-94.04%0.1045
63.10%-0.3449
-0.7931
-0.3689
-0.9687
15,880.80%1.7537
-0.9348
Diluted earnings per share
14.26%-0.68
-49.10%-0.55
-815.62%-8.87
-94.04%0.1045
63.10%-0.3449
-0.7931
-0.3689
-0.9687
15,880.80%1.7537
-0.9348
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 34.18%21.97M133.50%17.52M130.49%45.41M117.10%6.32M-52.68%9.38M16.37M7.5M19.7M-16,450.00%-36.95M19.82M
Selling and administrative expenses 224.84%6.24M349.89%6.14M499.59%13.04M31.64%-8.28M88.23%9.11M--1.92M--1.37M--2.18M-7,101.73%-12.11M--4.84M
-General and administrative expense 224.84%6.24M349.89%6.14M499.59%13.04M31.64%-8.28M88.23%9.11M--1.92M--1.37M--2.18M-7,101.73%-12.11M--4.84M
Research and development costs 8.86%15.73M85.37%11.38M84.69%32.37M158.77%14.6M-98.22%267K--14.45M--6.14M--17.53M-46,964.15%-24.84M--14.98M
Operating profit -34.18%-21.97M-133.50%-17.52M-130.49%-45.41M-117.10%-6.32M52.68%-9.38M-16.37M-7.5M-19.7M16,450.00%36.95M-19.82M
Net non-operating interest income expense 136.08%1.92M812K
Total other finance cost -----------------136.08%-1.92M-------------------812K
Other net income (expense) 1,730.20%4.48M4.21M3.29M13.71M449K245K
Special income (charges) ------------------449K------------------0
-Less:Restructuring and merger&acquisition ------------------89K------------------0
-Gain on sale of property,plant,equipment ------------------538K------------------0
Other non- operating income (expenses) 1,730.20%4.48M--4.21M--3.29M----------245K----------------
Income before tax -8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-94.04%2.13M63.10%-7.02M-16.13M-7.5M-19.7M15,880.97%35.67M-19.01M
Income tax
Net income -8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-94.04%2.13M63.10%-7.02M-16.13M-7.5M-19.7M15,880.97%35.67M-19.01M
Net income continuous Operations -8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-94.04%2.13M63.10%-7.02M---16.13M---7.5M---19.7M15,880.97%35.67M---19.01M
Minority interest income
Net income attributable to the parent company -8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-94.04%2.13M63.10%-7.02M-16.13M-7.5M-19.7M15,880.97%35.67M-19.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-94.04%2.13M63.10%-7.02M-16.13M-7.5M-19.7M15,880.97%35.67M-19.01M
Basic earnings per share 14.26%-0.68-49.10%-0.55-815.62%-8.87-94.04%0.104563.10%-0.3449-0.7931-0.3689-0.968715,880.80%1.7537-0.9348
Diluted earnings per share 14.26%-0.68-49.10%-0.55-815.62%-8.87-94.04%0.104563.10%-0.3449-0.7931-0.3689-0.968715,880.80%1.7537-0.9348
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg